Skip to content
Screener

SG&A at other companies

Eli Lilly logo
Eli LillyLLY
$3.43B+24.6%
AbbVie logo
AbbVieABBV
$3.63B+11.7%
Establishment Labs logo
Establishment LabsESTA
$46.91M+6.2%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$861M-0.7%

Other financials

Income statement

See full
Revenue$42.9M-2.5%
Gross profit$26.3M-1.8%
Operating income-$29.0K-104%
Net income-$1.1M-88.2%
EPS (diluted)-$0.02-100%

Balance sheet

See full
Cash & equivalents$18.8M+130%
Total debt$70.5M-17.4%
Total equity$104.8M+16.4%
Total assets$193.3M-2.6%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$228.0K-14.0%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$194M-50.2%
Enterprise value$245.64M-47.4%
P/S1.3×-1.1×

Profitability

See full
Gross margin59.7%+0.6pp
Operating margin-8.4%+14.7pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.3×
Current ratio0.8×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: AirSculpt Technologies, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 9:37 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001870940-26-000038
(in $000s, except for shares and per share figures)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue$42,900$44,012$82,289$83,383
Operating expenses:
Cost of service (exclusive of depreciation and amortization)16,56717,20132,15533,151
Selling, general and administrative23,42122,67146,00344,439
Depreciation and amortization2,9413,2465,9626,488
Loss on impairment of long-lived assets108108
Total operating expenses42,92943,22684,12084,186
(Loss)/income from operations(29)786(1,831)(803)

Item 1. Financial Statements

FAQ

What is AirSculpt Technologies, Inc.'s SG&A?
AirSculpt Technologies, Inc. (AIRS) reported SG&A of $23.42M in Q2 2026.
How has AirSculpt Technologies, Inc.'s SG&A changed year-over-year?
AirSculpt Technologies, Inc.'s SG&A increased by 3.3% year-over-year, from $22.67M to $23.42M.
What is the long-term trend for AirSculpt Technologies, Inc.'s SG&A?
Over 4 years (2021 to 2025), AirSculpt Technologies, Inc.'s SG&A has grown at a 5.7% compound annual growth rate (CAGR), from $65.78M to $82.18M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Ask your AI about AirSculpt Technologies, Inc.'s sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude